State Street’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.7M Sell
2,553,426
-312,074
-11% -$4.36M ﹤0.01% 1859
2025
Q1
$38.6M Sell
2,865,500
-657,066
-19% -$8.86M ﹤0.01% 1776
2024
Q4
$67.5M Buy
3,522,566
+1,142,792
+48% +$21.9M ﹤0.01% 1565
2024
Q3
$54.1M Sell
2,379,774
-392,605
-14% -$8.93M ﹤0.01% 1669
2024
Q2
$36.1M Sell
2,772,379
-1,716,236
-38% -$22.3M ﹤0.01% 1827
2024
Q1
$78.6M Buy
4,488,615
+1,780,232
+66% +$31.2M ﹤0.01% 1459
2023
Q4
$59M Sell
2,708,383
-233,307
-8% -$5.08M ﹤0.01% 1619
2023
Q3
$45.1M Buy
2,941,690
+23,321
+0.8% +$358K ﹤0.01% 1691
2023
Q2
$69.4M Buy
2,918,369
+516,557
+22% +$12.3M ﹤0.01% 1460
2023
Q1
$61.1M Buy
2,401,812
+538,622
+29% +$13.7M ﹤0.01% 1513
2022
Q4
$54.4M Buy
1,863,190
+684,641
+58% +$20M ﹤0.01% 1572
2022
Q3
$24.2M Buy
1,178,549
+723,484
+159% +$14.8M ﹤0.01% 2083
2022
Q2
$5.27M Buy
455,065
+389,065
+589% +$4.5M ﹤0.01% 3078
2022
Q1
$1.22M Buy
66,000
+31,959
+94% +$591K ﹤0.01% 3744
2021
Q4
$673K Buy
34,041
+10,200
+43% +$202K ﹤0.01% 3911
2021
Q3
$392K Buy
23,841
+12,800
+116% +$210K ﹤0.01% 4074
2021
Q2
$202K Buy
+11,041
New +$202K ﹤0.01% 4211
2020
Q4
Sell
-827
Closed -$10K 3909
2020
Q3
$10K Hold
827
﹤0.01% 3819
2020
Q2
$14K Hold
827
﹤0.01% 3784
2020
Q1
$6K Hold
827
﹤0.01% 3741
2019
Q4
$6K Hold
827
﹤0.01% 3796
2019
Q3
$9K Hold
827
﹤0.01% 3789
2019
Q2
$25K Sell
827
-24,726
-97% -$747K ﹤0.01% 3766
2019
Q1
$1.07M Buy
25,553
+1,502
+6% +$62.8K ﹤0.01% 3323
2018
Q4
$1.09M Sell
24,051
-792
-3% -$36K ﹤0.01% 3305
2018
Q3
$2.08M Buy
24,843
+4,458
+22% +$373K ﹤0.01% 3230
2018
Q2
$1.96M Buy
20,385
+9,309
+84% +$894K ﹤0.01% 3271
2018
Q1
$1.17M Buy
11,076
+917
+9% +$96.6K ﹤0.01% 3317
2017
Q4
$1.59M Buy
10,159
+2,431
+31% +$380K ﹤0.01% 3250
2017
Q3
$1.06M Buy
7,728
+658
+9% +$90.3K ﹤0.01% 3368
2017
Q2
$1.37M Buy
+7,070
New +$1.37M ﹤0.01% 3266